LENZ Therapeutics, Inc. (LENZ)
NASDAQ · Healthcare
LENZ Therapeutics, Inc. Income Statement 2024–2025
| Dec 2025 | Dec 2024 | |
|---|---|---|
| Revenues | ||
| Revenue | 19.1M | 0 |
| Gross Profit | 18.7M | 0 |
| Profitability | ||
| Operating Income | -91.1M | -58.6M |
| EBITDA | -90.9M | -58.6M |
| Net Income | -82.1M | -49.8M |
| Per Share Data | ||
| EPS (diluted) | $-2.85 | $-2.34 |
| Shares Outstanding (dil.) | 29M | 21M |
LENZ Therapeutics, Inc. Income Statement — FAQ
LENZ Therapeutics, Inc. (LENZ) income statement over the last 2 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see LENZ's income statement history?
The chart and table above show LENZ Therapeutics, Inc.'s income statement by year and by quarter, including the growth rate.